Longevity Health Holdings, Inc. (XAGE) - Dilution Analysis

10-K filing | 2.5M shares outstanding

8-K filing: Longevity Health Holdings, Inc. sold 689,656 shares of common stock to International Capital Partners LLC at $0.29 per share in a private placement, with the closing occurring on March 16, 2026. ($0.2M proceeds)

10-Q filing | 1.7M shares outstanding

10-Q filing | 1.8M shares outstanding

8-K filing: Longevity Health Holdings, Inc. entered into an Agreement and Plan of Merger with True Health Inc., where Longevity will acquire True Health in exchange for 19,666,667 shares of Longevity's common stock, valued at $3.00 per share, and will acquire TMG's right, title and interest in and to the authorizations, approvals, licenses, permits, certificates, registrations or exemptions issued by the U.S. Food and Drug Administration that are required for the research, development, collection, manufacture, processing, labeling, distribution, marketing, storage, transportation, use, sale and provision of True Health's products.

8-K filing: Longevity Health Holdings, Inc. announced the successful sale of 479,621 shares of its common stock at an average price of $4.08 per share through its at-the-market (ATM) equity offering facility, resulting in gross proceeds of approximately $1.96 million. ($0.0M proceeds)

10-Q filing | 1.0M shares outstanding

8-K filing: Stock split 1-for-30 | Outstanding: 30,119,843 → 1,002,990

POS AM filing: This POS AM filing relates to the offer and resale of common stock by selling stockholders, and also discusses a private placement of common stock and warrants.

10-K filing | 30.1M shares outstanding

S-3 filing: Carmell Corporation files an S-3 to offer common stock, preferred stock, and debt securities, with the selling stockholders offering up to 17,397,460 shares of common stock.

8-K filing: Carmell Corporation entered into a securities purchase agreement to sell 8,065,210 shares of common stock at $0.23 per share and warrants to purchase up to 8,065,210 shares of common stock at an exercise price of $0.23 per share in a private placement, expecting gross proceeds of approximately $1.85 million. ($0.0M proceeds)

10-Q filing | 20.9M shares outstanding

10-Q filing | 20.7M shares outstanding

S-1/A filing: This S-1/A filing covers the offer and resale by selling stockholders of up to 1,331,452 shares of common stock that were issued to the Selling Stockholders pursuant to a Securities Purchase Agreement.

10-Q filing | 20.8M shares outstanding

S-1 filing: This S-1 filing covers the offer and resale by selling stockholders of up to 1,331,452 shares of common stock that were issued to the Selling Stockholders pursuant to a Securities Purchase Agreement in a private placement.

8-K filing: Carmell Corporation entered into a securities purchase agreement for the sale of 1,331,452 shares of common stock at $2.25 per share for unaffiliated investors and $2.88 per share for the Company's Chief Executive Officer, with gross proceeds expected to be approximately $3.0 million. ($3.0M proceeds)

10-K filing | 19.2M shares outstanding

8-K filing: Carmell Corporation sold all outstanding limited liability company interests of Axolotl Biologix, LLC to the Buyers in exchange for 3,845,337 shares of the Company's common stock, 4,243 shares of the Company's Series A Convertible Voting Preferred Stock, and cancellation of $8 million in notes payable.

10-Q filing | 23.1M shares outstanding

10-Q filing | 19.2M shares outstanding

S-1 filing: The filing relates to the issuance of up to 3,976,997 shares of common stock upon the exercise of warrants.

10-Q filing | 15.9M shares outstanding

10-K filing | 15.9M shares outstanding

10-Q filing | 15.9M shares outstanding

10-Q filing | 15.9M shares outstanding

10-Q filing | 15.9M shares outstanding

10-K filing | 15.9M shares outstanding

10-Q filing | 15.9M shares outstanding

10-Q filing | 15.0M shares outstanding

8-K filing: Alpha Healthcare Acquisition Corp. III consummated an initial public offering of 15,000,000 units at $10.00 per unit and a private placement of 455,000 units at $10.00 per unit, with the proceeds placed in a trust account. ($154.55M proceeds)

S-1/A filing: Alpha Healthcare Acquisition Corp. III is offering 15,000,000 units at $10.00 per unit, each unit consisting of one share of Class A common stock and one-fourth of one redeemable warrant.

S-1/A filing: Alpha Healthcare Acquisition Corp. III is offering 15,000,000 units at $10.00 per unit for a total of $150,000,000.

S-1/A filing: Alpha Healthcare Acquisition Corp. III is offering 15,000,000 units at $10.00 per unit, each unit consisting of one share of Class A common stock and one-fourth of one redeemable warrant.

S-1/A filing: This is the initial public offering of Alpha Healthcare Acquisition Corp. III, a blank check company, consisting of 15,000,000 units at $10.00 per unit, each unit comprising one share of Class A common stock and one-fourth of one redeemable warrant.

S-1 filing: Alpha Healthcare Acquisition Corp. III is offering 15,000,000 units at $10.00 per unit, each unit consisting of one share of Class A common stock and one-fourth of one redeemable warrant, in an initial public offering.